These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

137 related items for PubMed ID: 2147602

  • 1. Glucagon in women with polycystic ovary syndrome (PCO): relationship to abnormalities of insulin and androgens.
    Golland IM, Vaughan Williams CA, Shalet SM, Laing I, Elstein M.
    Clin Endocrinol (Oxf); 1990 Nov; 33(5):645-51. PubMed ID: 2147602
    [Abstract] [Full Text] [Related]

  • 2. The impact of obesity and chronic hyperinsulinemia on gonadotropin release and gonadal steroid secretion in the polycystic ovary syndrome.
    Dunaif A, Mandeli J, Fluhr H, Dobrjansky A.
    J Clin Endocrinol Metab; 1988 Jan; 66(1):131-9. PubMed ID: 2961783
    [Abstract] [Full Text] [Related]

  • 3. The relationship of insulin insensitivity to menstrual pattern in women with hyperandrogenism and polycystic ovaries.
    Robinson S, Kiddy D, Gelding SV, Willis D, Niththyananthan R, Bush A, Johnston DG, Franks S.
    Clin Endocrinol (Oxf); 1993 Sep; 39(3):351-5. PubMed ID: 8222298
    [Abstract] [Full Text] [Related]

  • 4. Lack of linear relationship between hyperinsulinaemia and hyperandrogenism.
    Toscano V, Bianchi P, Balducci R, Guglielmi R, Mangiantini A, Lubrano C, Sciarra F.
    Clin Endocrinol (Oxf); 1992 Feb; 36(2):197-202. PubMed ID: 1533185
    [Abstract] [Full Text] [Related]

  • 5. [Insulin resistance and serum concentrations of ovarian and adrenal androgen in obese women without additional disease and with policystic ovary syndrome].
    Olszanecka-Glinianowicz M, Banaś M, Zahorska-Markiewicz B, Kuglin D, Mokrzycka J, Mentel A.
    Endokrynol Pol; 2005 Feb; 56(6):921-6. PubMed ID: 16821212
    [Abstract] [Full Text] [Related]

  • 6. Plasma androgens and oestradiol during oral glucose tolerance test in patients with polycystic ovaries.
    Tiitinen A, Pekonen F, Stenman UH, Laatikainen T.
    Hum Reprod; 1990 Apr; 5(3):242-5. PubMed ID: 2191000
    [Abstract] [Full Text] [Related]

  • 7. [Correlation between hormonal and metabolic profiles in women with polycystic ovary syndrome].
    Esposito V, Federico P, Lo Iudice G, Rispoli C, Sabatino P, D'Alessandro B.
    Minerva Endocrinol; 1992 Apr; 17(1):21-9. PubMed ID: 1495451
    [Abstract] [Full Text] [Related]

  • 8. Insulin resistance in patients with polycystic ovaries: its relationship to body weight and androgen levels.
    Pasquali R, Casimirri F, Venturoli S, Paradisi R, Mattioli L, Capelli M, Melchionda N, Labò G.
    Acta Endocrinol (Copenh); 1983 Sep; 104(1):110-6. PubMed ID: 6137924
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Characterization of groups of hyperandrogenic women with acanthosis nigricans, impaired glucose tolerance, and/or hyperinsulinemia.
    Dunaif A, Graf M, Mandeli J, Laumas V, Dobrjansky A.
    J Clin Endocrinol Metab; 1987 Sep; 65(3):499-507. PubMed ID: 3305551
    [Abstract] [Full Text] [Related]

  • 11. Body mass index and ovarian function are associated with endocrine and metabolic abnormalities in women with hyperandrogenic syndrome.
    Cupisti S, Kajaia N, Dittrich R, Duezenli H, W Beckmann M, Mueller A.
    Eur J Endocrinol; 2008 May; 158(5):711-9. PubMed ID: 18426831
    [Abstract] [Full Text] [Related]

  • 12. An abnormality of the growth hormone/insulin-like growth factor-I axis in women with polycystic ovary syndrome due to coexistent obesity.
    Slowinska-Srzednicka J, Zgliczynski W, Makowska A, Jeske W, Brzezinska A, Soszynski P, Zgliczynski S.
    J Clin Endocrinol Metab; 1992 Jun; 74(6):1432-5. PubMed ID: 1534330
    [Abstract] [Full Text] [Related]

  • 13. Obesity, weight loss, and the polycystic ovary syndrome: effect of treatment with diet and orlistat for 24 weeks on insulin resistance and androgen levels.
    Panidis D, Farmakiotis D, Rousso D, Kourtis A, Katsikis I, Krassas G.
    Fertil Steril; 2008 Apr; 89(4):899-906. PubMed ID: 17980364
    [Abstract] [Full Text] [Related]

  • 14. Correlation of plasma insulin and insulin-like growth factor-I with indices of androgen transport and metabolism in women with polycystic ovary syndrome.
    Sharp PS, Kiddy DS, Reed MJ, Anyaoku V, Johnston DG, Franks S.
    Clin Endocrinol (Oxf); 1991 Sep; 35(3):253-7. PubMed ID: 1742883
    [Abstract] [Full Text] [Related]

  • 15. Insulin, C-peptide, androgens, and beta-endorphin response to oral glucose in patients with polycystic ovary syndrome.
    Tropeano G, Lucisano A, Liberale I, Barini A, Vuolo IP, Martino G, Menini E, Dell'Acqua S.
    J Clin Endocrinol Metab; 1994 Feb; 78(2):305-9. PubMed ID: 8106616
    [Abstract] [Full Text] [Related]

  • 16. The association of serum androgens and insulin resistance with fat distribution in polycystic ovary syndrome.
    Yucel A, Noyan V, Sagsoz N.
    Eur J Obstet Gynecol Reprod Biol; 2006 May 01; 126(1):81-6. PubMed ID: 16337726
    [Abstract] [Full Text] [Related]

  • 17. Metabolic features of polycystic ovary syndrome are found in adolescent girls with hyperandrogenism.
    Apter D, Bützow T, Laughlin GA, Yen SS.
    J Clin Endocrinol Metab; 1995 Oct 01; 80(10):2966-73. PubMed ID: 7559882
    [Abstract] [Full Text] [Related]

  • 18. Insulin, androgens, and obesity in women with and without polycystic ovary syndrome: a heterogeneous group of disorders.
    Acién P, Quereda F, Matallín P, Villarroya E, López-Fernández JA, Acién M, Mauri M, Alfayate R.
    Fertil Steril; 1999 Jul 01; 72(1):32-40. PubMed ID: 10428145
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. The independent effects of polycystic ovary syndrome and obesity on serum concentrations of gonadotrophins and sex steroids in premenopausal women.
    Holte J, Bergh T, Gennarelli G, Wide L.
    Clin Endocrinol (Oxf); 1994 Oct 01; 41(4):473-81. PubMed ID: 7955458
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 7.